Use of heterologous vesiculovirus G proteins circumvents the humoral anti-envelope immunity in lentivector-based in vivo gene delivery (Molecular Therapy - Nucleic Acids, 2019)

(untitled) - Munis, A; Mattiuzzo, G; Bentley, E; Collins, M; Eyles, J; Takeuchi, Y